Blue Bell / Pennsylvania / United States
Achillion Pharmaceuticals is an innovative pharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. The company s proven discovery and development teams have advanced multiple product candidates with novel mechanisms of action. Achillion is focused on solutions for the most challenging problems in infectious disease, HIV, hepatitis and resistant bacterial infections. Achillion s drug discovery pipeline embodies an innovative program-based approach to identifying new infectious disease targets and designing small molecule drugs to attack these targets, with a particular emphasis on antiviral drugs to treat diseases caused by hepatitis C viruses and the human immunodeficiency virus as well as new anti-microbial drugs.
